Role of Matrix Metalloproteinase 3 in Predicting the Efficiency of Therapy for Early Rheumatoid Arthritis: The Remarca Trial

Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2016-38-43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Possible Involvement of Matrix Metalloproteinase-3 in the Pathogenesis of Macroprolactinaemia in Some Patients With Rheumatoid Arthritis

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2013English

A Randomised Controlled Trial of Occupational Therapy for People With Early Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

Role of Matrix Metalloproteinases in Joint Destruction in Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2004English

AB0435 Combination Therapy in Early Stage of Rheumatoid Arthritis

2017English

Continuously Elevated Serum Matrix Metalloproteinase-3 for 3 ~ 6 Months Predict One-Year Radiographic Progression in Rheumatoid Arthritis: A Prospective Cohort Study

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

P170 Potential Role for the Chemokine CCL22 in the Development and Early Progression of Rheumatoid Arthritis

2019English

Iron Therapy in the Anaemia of Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1951English

Aggressive Treatment in Early Rheumatoid Arthritis: A Randomised Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Adalimumab in the Treatment of Early Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy